市場調查報告書
商品編碼
1447639
骨移植替代品市場-依材料類型[同種異體移植(DBM)、合成(聚合物、陶瓷、複合材料)]、應用(脊椎融合、牙科、關節重建、足踝、顱顎面、長骨)、最終用途-全球預測, 2024-2032Bone Graft Substitutes Market-By Material Type [Allograft (DBM), Synthetic (Polymer, Ceramics, Composites)], Application (Spinal Fusion, Dental, Joint Reconstruction, Foot & Ankle, Craniomaxillofacial, Long Bone), End-use-Global Forecast, 2024-2032 |
由於導致骨折和缺損的創傷病例數量不斷增加,2024年至2032年全球骨移植替代品市場規模將創下6.6%的CAGR。骨移植替代品在幫助創傷患者骨再生和修復方面發揮著至關重要的作用。創新生物材料和合成替代品等醫療技術的快速進步正在提高骨移植解決方案的有效性和可用性。這些因素的結合將推動該行業在滿足創傷患者的需求和改善手術結果方面的成長。例如,2023 年 5 月,Royal Biologics 推出了 Bio-Reign 3D 骨移植替代品,這是其產品線中的新型產品,設計為在植入時具有射線可穿透性。
骨移植替代品市場分為材料類型、應用、最終用途和區域。
根據材料類型,在合成替代品的優勢(例如可用性、成本效益和降低疾病傳播風險)的推動下,合成細分市場將實現顯著的收入佔有率,到 2032 年CAGR為 7%。合成骨移植物,包括陶瓷和聚合物,具有非常模仿天然骨的特性,可促進骨再生。此外,在骨科和牙科手術中擴大採用合成材料,以及對創新和生物相容性骨移植替代品的需求不斷成長,將促進該領域的成長。
由於牙科疾病的盛行率不斷上升以及對牙植體和手術的需求不斷成長,牙科應用領域的骨移植替代品市場從 2024 年到 2032 年的CAGR將達到 7.3%。骨移植替代品在牙科應用中發揮著至關重要的作用,有助於種植體植入和牙周治療的骨再生。此外,牙科技術和材料的進步正在推動這些替代品的採用。隨著人們對口腔健康和美觀的日益重視,產品在牙科應用中的採用率將進一步飆升。
在老年人口不斷擴大、骨科疾病盛行率上升以及先進醫療技術日益普及的推動下,亞太地區骨移植替代品產業規模從 2024 年到 2032 年將呈現 7.6% 的CAGR。中國和印度等國家因其龐大的患者群體和改善的醫療基礎設施而極大地促進了骨移植替代品的需求。此外,對再生醫學的日益關注以及具有成本效益的骨移植替代品的可用性的提高將進一步促進區域市場的擴張。
Global Bone Graft Substitutes Market size will record 6.6% CAGR from 2024 to 2032, attributed to the increasing number of trauma cases resulting in bone fractures and defects. Bone graft substitutes play a crucial role in aiding bone regeneration and repair in trauma patients. Rapid advancements in medical technology, such as innovative biomaterials and synthetic substitutes are enhancing the effectiveness and availability of bone grafting solutions. This combination of factors will propel the industry growth in meeting the needs of trauma patients and improving surgical outcomes. For instance, in May 2023, Royal Biologics introduced the Bio-Reign 3D bone graft substitute, a novel product in its line designed to be radiolucent upon implantation.
The bone graft substitutes market is divided into material type, application, end-use, and region.
Based on material type, the synthetic segment will achieve a noteworthy revenue share, depicting 7% CAGR through 2032, fueled by advantages of synthetic substitutes, such as availability, cost-effectiveness, and reduced risk of disease transmission. Synthetic bone grafts, including ceramics and polymers, offer properties that closely mimic natural bone for promoting bone regeneration. Additionally, the increasing adoption of synthetic materials in orthopedic and dental procedures along with the rising demand for innovative and biocompatible bone graft substitutes will add to the segment growth.
Bone graft substitutes market from the dental application segment will garner 7.3% CAGR from 2024 to 2032, due to the increasing prevalence of dental disorders and the rising demand for dental implants and procedures. Bone graft substitutes play a vital role in dental applications in aiding in bone regeneration for implant placements and periodontal treatments. Moreover, advancements in dental technology and materials are fueling the adoption of these substitutes. With the growing emphasis on oral health and aesthetics, the product adoption will further soar in dental applications.
Asia Pacific bone graft substitutes industry size will demonstrate 7.6% CAGR from 2024 to 2032, driven by the expanding geriatric population, rising prevalence of orthopedic conditions, and the increasing adoption of advanced medical technologies. Countries like China and India are significantly contributing to the demand for bone graft substitutes with their large patient population and improved healthcare infrastructure. Additionally, the growing focus on regenerative medicine and the higher availability of cost-effective bone graft substitutes will further bolster the regional market expansion.